| Source: |
| Type: |
| Autophagy Regulator: – ATG7 is an E1-like enzyme crucial for the autophagy pathway. – It participates in the conjugation systems that drive autophagosome formation (e.g., ATG12–ATG5 and LC3 lipidation systems). • Elevated Expression: – In certain cancers (e.g., pancreatic cancer, some subtypes of breast cancer), ATG7 can be upregulated. – Increased ATG7 expression in some contexts is thought to help tumors survive under metabolic stress by enhancing autophagy. • Reduced Expression or Loss-of-Function: – In other contexts – for instance, in some liver cancers or specific lung cancers – reduced expression or inactivation of ATG7 has been reported. – This reduction might lead to failure of effective autophagy in tumor-suppressive contexts. |
| none (reserved) |
| 1571- | Cu, | Copper in cancer: From pathogenesis to therapy |
| - | Review, | NA, | NA |
| 2865- | HNK, | Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma |
| - | in-vitro, | MB, | DAOY | - | vitro+vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:986 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid